<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">ETM</journal-id>
<journal-title-group>
<journal-title>Experimental and Therapeutic Medicine</journal-title></journal-title-group>
<issn pub-type="ppub">1792-0981</issn>
<issn pub-type="epub">1792-1015</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/etm.2013.991</article-id>
<article-id pub-id-type="publisher-id">etm-05-05-1439</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>Associations of plasma atrial natriuretic peptide and electrolyte levels with essential hypertension</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>HU</surname><given-names>GUANGMEI</given-names></name><xref rid="af1-etm-05-05-1439" ref-type="aff"><sup>1</sup></xref></contrib>
<contrib contrib-type="author">
<name><surname>XU</surname><given-names>XINJUAN</given-names></name><xref ref-type="corresp" rid="c1-etm-05-05-1439"/><xref rid="af1-etm-05-05-1439" ref-type="aff"><sup>1</sup></xref><xref rid="af2-etm-05-05-1439" ref-type="aff"><sup>2</sup></xref></contrib>
<contrib contrib-type="author">
<name><surname>LIANG</surname><given-names>XIAOHUI</given-names></name><xref rid="af1-etm-05-05-1439" ref-type="aff"><sup>1</sup></xref></contrib>
<contrib contrib-type="author">
<name><surname>YANG</surname><given-names>XIAOPING</given-names></name><xref rid="af1-etm-05-05-1439" ref-type="aff"><sup>1</sup></xref></contrib>
<contrib contrib-type="author">
<name><surname>ZHANG</surname><given-names>JUNSHI</given-names></name><xref rid="af1-etm-05-05-1439" ref-type="aff"><sup>1</sup></xref></contrib>
<contrib contrib-type="author">
<name><surname>SIMAYI</surname><given-names>ZHULEPIYA</given-names></name><xref rid="af1-etm-05-05-1439" ref-type="aff"><sup>1</sup></xref></contrib>
<contrib contrib-type="author">
<name><surname>CHEN</surname><given-names>YULAN</given-names></name><xref rid="af1-etm-05-05-1439" ref-type="aff"><sup>1</sup></xref></contrib></contrib-group>
<aff id="af1-etm-05-05-1439">
<label>1</label>State Key Laboratory Incubation Base of Xinjiang Major Diseases Research;</aff>
<aff id="af2-etm-05-05-1439">
<label>2</label>First Affiliated Hospital of Xinjiang Medical University, Urumchi, Xinjiang 830054, 
<country>P.R. China</country></aff>
<author-notes>
<corresp id="c1-etm-05-05-1439">Correspondence to: Dr Xinjuan Xu, First Affiliated Hospital of Xinjiang Medical University, 137 Liyushannan Road, Urumchi, Xinjiang 830054, P.R. China, E-mail: <email>gmxjcn@163.com</email></corresp></author-notes>
<pub-date pub-type="ppub">
<month>5</month>
<year>2013</year></pub-date>
<pub-date pub-type="epub">
<day>06</day>
<month>03</month>
<year>2013</year></pub-date>
<volume>5</volume>
<issue>5</issue>
<fpage>1439</fpage>
<lpage>1443</lpage>
<history>
<date date-type="received">
<day>19</day>
<month>11</month>
<year>2012</year></date>
<date date-type="accepted">
<day>22</day>
<month>01</month>
<year>2013</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2013, Spandidos Publications</copyright-statement>
<copyright-year>2013</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions>
<abstract>
<p>This study aimed to investigate the associations among the levels of plasma atrial natriuretic peptide (ANP) and electrolytes and essential hypertension (EH) in Uygur, Han and Kazakh populations in Xinjiang. A total of 724 hypertensive participants of different ethnicities from Xinjiang (208 Uygur, 287 Han and 229 Kazakh) and 741 normal controls (208 Uygur, 267 Han and 266 Kazakh) were enrolled. The associations of ANP with serum potassium, serum sodium and blood pressure were assessed. In the normal control (NT) group, the concentration of ANP was higher in the Uygur population than in the Han population, and the concentration in the Han population was higher than that in the Kazakh population (P&#x0003C;0.05). In the EH group, the serum potassium levels of the Uygur and Han populations were higher than that of the Kazakh population (P&#x0003C;0.05). The ANP concentration in the Uygur ethnic group was higher than that in the Han population, which was in turn higher than that in the Kazakh participants (P&#x0003C;0.05). In the Kazakh population, the serum potassium level was significantly lower in the EH group compared with that in the NT group (P&#x0003C;0.05). The serum potassium level was significantly lower and the ANP concentration significantly higher in the EH group compared with those of NT groups in the Uygur and Han populations (P&#x0003C;0.05). Age and body mass index (BMI) were associated with hypertension in the Uygur, Han and Kazakh populations. Low serum potassium may be a risk factor of hypertension in individuals of Uygur and Kazakh ethnicity. Plasma ANP may be a regulatory factor involved in the development of hypertension in Uygur and Han populations.</p></abstract>
<kwd-group>
<kwd>hypertension</kwd>
<kwd>Uygur nationality</kwd>
<kwd>Han nationality</kwd>
<kwd>Kazakh nationality</kwd>
<kwd>atrial natriuretic peptide</kwd>
<kwd>electrolytes</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Essential hypertension (EH) is a common cardiovascular disease, affecting &#x0223C;25&#x00025; of adults globally. It is expected that by 2025, its prevalence will have increased to 60&#x00025;; a total population of 1.56 billion may suffer from hypertension (<xref rid="b1-etm-05-05-1439" ref-type="bibr">1</xref>). EH accounts for 95&#x00025; of all cases of hypertension (<xref rid="b2-etm-05-05-1439" ref-type="bibr">2</xref>). Hypertension is a complex syndrome influenced by multiple genetic and environmental factors (<xref rid="b3-etm-05-05-1439" ref-type="bibr">3</xref>). In view of some individuals being more susceptible to hypertension than others, it is essential to explain this interindividual differential susceptibility (<xref rid="b4-etm-05-05-1439" ref-type="bibr">4</xref>). Although genome-wide association studies have been expected to unlock the genetic basis of hypertension, the results from such studies, however, yielded little information (<xref rid="b5-etm-05-05-1439" ref-type="bibr">5</xref>).</p>
<p>As research has progressed, it has been identified that abnormalities in electrolyte metabolism play a role in the pathogenesis of hypertension (<xref rid="b6-etm-05-05-1439" ref-type="bibr">6</xref>). Atlas <italic>et al</italic>(<xref rid="b7-etm-05-05-1439" ref-type="bibr">7</xref>) indicated that atrial natriuretic factor has potentially important interactions with the renin-angiotensin-aldosterone system and suggest a role for atrial natriuretic peptide (ANP) in the homeostatic control of blood pressure (BP) as well as of extracellular fluid volume. The study by Wang <italic>et al</italic>(<xref rid="b8-etm-05-05-1439" ref-type="bibr">8</xref>), which concerned the epidemiology of hypertension in different ethnicities in the Turpan, Hami and Altay regions of Xinjiang, indicated that the average daily intake of salt for Kazakh, Uygur and Han individuals is 19, 15.5 and 9 g, respectively, and the standardized hypertension rates reported for Kazakh, Han and Uygur individuals were 15.32, 4.27 and 2.11&#x00025;, respectively. High-sodium, low-potassium diets are widespread in the Xinjiang region.</p>
<p>The natriuretic peptides, specifically ANP, are increasingly recognized to play a fundamental role in BP regulation. This role in BP regulation reflects the pluripotent cardiorenal actions of ANP, which include diuresis, enhancement of renal blood flow and glomerular filtration rate, systemic vasodilatation, suppression of aldosterone and inhibition of the sympathetic nervous system. These actions of ANP, in addition to recent human studies demonstrating an association between higher plasma ANP and a lower risk of hypertension, support the development of an ANP-based therapy for hypertension. In an animal model of hypertension, M-atrial natriuretic peptide (M-ANP) has been demonstrated to reduce BP (<xref rid="b9-etm-05-05-1439" ref-type="bibr">9</xref>), and another study identified that in rural Chinese patients with EH, ANP Val7Met polymorphism may be a genetic marker for baseline diastolic BP (DBP) (<xref rid="b10-etm-05-05-1439" ref-type="bibr">10</xref>).</p>
<p>We therefore aimed to evaluate the association between serum sodium, potassium and ANP in hypertensive patients of Uygur, Kazakh and Han ethnicity in Xinjiang.</p></sec>
<sec sec-type="methods">
<title>Material and methods</title>
<sec>
<title>Study group</title>
<p>This study was conducted in accordance with the Declaration of Helsinki and with approval from the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University (Urumchi, China). Written informed consent was obtained from all participants. The study adopted a random cluster sampling method. The participants recruited were between 30 and 60 years old. They were divided into a hypertension group (EH) and a control group (NT) according to &#x02018;the China high blood pressure control guide&#x02019; diagnosis standard (<xref rid="b11-etm-05-05-1439" ref-type="bibr">11</xref>). The Uyghur population originates from the Hotan region Moyu Xian to the south of Xinjiang, the Kazakh population from Balikun Xian to the east of Xinjiang and Yumin Xian to the north of Xinjiang, and the Han population from the Balikun, Yumin Xian and Turpan regions. The participants of all ethnicities were unrelated with no history of interethnic marriage.</p></sec>
<sec>
<title>Exclusion criteria</title>
<p>In the EH group, patients with secondary high BP, excessive drinking, secondary medication history or a history of diabetes or liver, kidney or thyroid disease were excluded. In the NT group, individuals were excluded due to liver, kidney or thyroid dysfunction, a history of diabetes or high BP.</p></sec>
<sec>
<title>Investigative methods</title>
<p>We adopted a random method for evaluating the study participants by a questionnaire survey and BP, height, weight and the abdominal circumference were measured. The questionnaire survey content included: general situation, history of hypertension, two weeks of taking BP medication, smoking and drinking, hypertension, family history, etc. When measuring height and weight, shoes and hats were removed. The smallest units of height and weight were 1 cm and 0.5 kg respectively. From the height and weight measurements, the body mass index (BMI) was calculated and the participants were identified as being overweight if their BMI was &#x02265;25 kg/m<sup>2</sup> and obese if their BMI was &#x02265;30 kg/m<sup>2</sup>.</p></sec>
<sec>
<title>BP measurement</title>
<p>Nurse-derived conventional BP was measured after 10 min of rest in the seated position within 30 min of obtaining blood samples from the opposite arm to that subjected to venesection. Five consecutive BP readings were obtained using an appropriately sized cuff, 30&#x02013;60 sec apart. The average of the five readings was taken as the BP.</p></sec>
<sec>
<title>Blood samples and biochemical tests</title>
<p>Blood samples were obtained from participants having an empty stomach after 10 min of rest between 10:00 and 12:00 in the morning. Participants were allowed to continue taking all routine medications when blood was taken, with the exception of K<sup>&#x0002B;</sup>-sparing diuretics and loop diuretics. After centrifuging, samples were stored at &#x02212;20&#x000B0;C until the time of analysis. Serum potassium and sodium levels were measured using a Hitachi 7020 biochemical analyzer (Hitachi Ltd., Tokyo, Japan). A plasma ANP radioimmunoassay kit was provided by the North Biotechnology Research Institute (Beijing, China), and procedures were carried out according to the manufacturer&#x02019;s instructions, using a GC-1500 &#x003B3; radiation counter.</p></sec>
<sec>
<title>Statistical analysis</title>
<p>For database management and statistical analysis, SPSS software, version 13.0 (SPSS, Inc., Chicago, IL, USA) was employed. Data are shown as the mean &#x000B1; SD unless otherwise specified. Comparison between two groups used a t-test. Comparison between three groups used one-factor analysis of variance. Correlations with BP were determined from multivariate regression models with age, BMI, serum potassium, serum sodium and the concentration of ANP included in the regression models.</p></sec></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Comparison of electrolytes and ANP between the EH and NT groups of Kazakh ethnicity</title>
<p><xref rid="t1-etm-05-05-1439" ref-type="table">Table I</xref> shows a comparison of age, BMI, serum potassium, serum sodium and the concentration of ANP in the Kazakh population. It may be observed that the serum potassium level was significantly lower and the systolic blood pressure (SBP), DBP, age and BMI were significantly higher in the EH group than in the NT group (P&#x0003C;0.05). No significant difference was observed in the concentration of ANP between the EH and NT groups (P&#x0003E;0.05).</p>
<p>With the existence of hypertension as the dependent variable and age, BMI and serum potassium as covariates, the logistic regression equation was as follows: BP&#x0003D;&#x02212;1.52 &#x0002B; 0.14age - 2.04serum potassium &#x0002B; 0.16BMI. It indicates that in the Kazakh population, hypertension, in addition to being affected by age and BMI, also has low serum potassium as a risk factor.</p></sec>
<sec>
<title>Comparison of electrolytes and ANP between the EH and NT groups of Uygur ethnicity</title>
<p><xref rid="t2-etm-05-05-1439" ref-type="table">Table II</xref> shows a comparison of age, BMI, serum potassium, serum sodium and the concentration of ANP in the Uygur population. It may be observed that the serum potassium level was significantly lower and SBP, DBP, age, BMI and ANP concentration were significantly higher in the EH group compared with those in the NT group (P&#x0003C;0.05). No significant difference was observed in serum sodium level between the EH and NT groups (P&#x0003E;0.05).</p>
<p>With the existence of hypertension as the dependent variable and age, BMI, serum potassium and ANP as covariates, the logistic regression equation was as follows: BP&#x0003D;&#x02212;4.65 &#x0002B;0.05age - 0.49serum potassium &#x0002B; 0.17BMI. It indicates that in the Uygur population, hypertension, in addition to being affected by age and BMI, also has low serum potassium as a risk factor.</p></sec>
<sec>
<title>Comparison of electrolytes and ANP between the EH and NT groups of Han ethnicity</title>
<p><xref rid="t3-etm-05-05-1439" ref-type="table">Table III</xref> shows a comparison of age, BMI, serum potassium, serum sodium and the concentration of ANP in the Han population. It may be observed that the serum potassium level was significantly lower and the SBP, DBP, age, BMI and ANP concentration significantly higher in the EH group compared with those in the NT group (P&#x0003C;0.05). No significant difference was observed in serum sodium level between the EH and NT groups (P&#x0003E;0.05).</p>
<p>Using the existence of hypertension as the dependent variable and age, BMI and serum potassium as covariates, the logistic regression equation was as follows: BP&#x0003D;&#x02212;10.27 &#x0002B; 0.15age &#x0002B; 0.14BMI. It indicates that hypertension in Han individuals is mainly affected by age and BMI.</p></sec>
<sec>
<title>Comparison of electrolytes and ANP among the NT groups of different ethnicities</title>
<p><xref rid="t4-etm-05-05-1439" ref-type="table">Table IV</xref> compares the age, BMI, serum potassium, serum sodium and concentration of ANP in the NT groups of different ethnicities. It indicates that in the NT group, there were no significant differences in serum potassium or serum sodium level among the Uygur, Han and Kazakh populations (P&#x0003E;0.05). The concentration of ANP was higher in the Uygur population than in the Han, and the concentration in the Han population was higher than in the Kazakh (P&#x0003C;0.05).</p></sec>
<sec>
<title>Comparison of electrolytes and ANP among the EH groups of different ethnicities</title>
<p><xref rid="t5-etm-05-05-1439" ref-type="table">Table V</xref> compares the age, BMI, serum potassium, serum sodium and concentration of ANP in the EH groups of different ethnicities. In the EH group, there were no significant differences in serum sodium level among the Uygur, Han and Kazakh populations (P&#x0003E;0.05). The levels of serum potassium in the Uygur and Han were higher than those in the Kazakh population (P&#x0003C;0.05). The concentration of ANP was higher in the Uygur population than in the Han, and the concentration in the Han population was higher than in the Kazakh (P&#x0003C;0.05).</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>The etiology and pathogenesis of EH have not yet been fully elucidated; at present most of the theories accept that genetic factors and environmental factors play a role. Among the environmental factors, lifestyle (including mental stress and psychological pressure, long-term lack of sleep, erratic lifestyle, fatigue, lack of physical activity, alcohol intake and smoking), dietary factors (including a high-salt, high-fat, high-calorie and/or low-potassium diet, low vegetable intake, and being obese or overweight), and aging may lead to high BP. In most areas of Xinjiang, high-salt diets are prevalent, and diets also tend to be low in potassium. A number of epidemiological studies suggest that there is close relationship between electrolyte and BP levels (<xref rid="b12-etm-05-05-1439" ref-type="bibr">12</xref>&#x02013;<xref rid="b17-etm-05-05-1439" ref-type="bibr">17</xref>). ANP is a regulator of BP-active peptides. ANP is mainly synthesized by atrial myocytes and released by relaxing blood vessels, where it acts by reducing peripheral resistance, increasing the glomerular filtration rate, inhibiting renin release and causing significant increases in urinary sodium excretion and urine output; this mechanism is involved in the regulation of BP. The current study focuses on the electrolyte and ANP levels in hypertensive patients of different ethnicities from the Xinjiang region, and aims to explore the role of the electrolytes and ANP in the pathogenesis of hypertension.</p>
<p>The results suggest that there is significant hypokalemia in the hypertensive Uygur, Kazakh and Han populations and there is an association between hypokalemia and hypertension in Uygur and Kazakh populations. However, no significant difference was observed among the serum potassium levels in the three ethnic groups of patients with normal BP. Considerable evidence has shown that potassium deficiency plays a key role in hypertension and its sequelae (<xref rid="b18-etm-05-05-1439" ref-type="bibr">18</xref>&#x02013;<xref rid="b20-etm-05-05-1439" ref-type="bibr">20</xref>). The possible mechanism by which reductions in serum potassium affect BP is that they lead to reduced urinary excretion of sodium, the retention of sodium by the body and an increase in the volume of extracellular fluid. A low potassium intake may therefore exacerbate the high-salt-mediated pressor effect. Increases in K<sup>&#x0002B;</sup> intake promote the excretion of sodium and curb volume expansion, which may prevent salt-mediated elevations in BP (<xref rid="b21-etm-05-05-1439" ref-type="bibr">21</xref>).</p>
<p>In the present study, no significant differences were observed in serum sodium among the different ethnicities, but the concentration of ANP was highest in the Uygur population, intermediate in the Han and lowest in the Kazakh. Atrial stretch is the main factor affecting ANP synthesis and secretion. In addition, salt intake, elevated extracellular fluid osmolarity, enhanced blood volume, rapid heart rate and neurohumoral factors directly affect the pressure on the atrial muscle and the release of ANP.</p>
<p>The results suggest that in this case there was no difference in serum sodium levels among the different ethnic groups of patients with hypertension. However, the level of ANP in Uygur is higher than Han and Kazakh hypertensive, and the level of ANP in Han is higher than Kazakh hypertensive. Serum sodium levels are able to stimulate ANP effects on BP regulation, this is why the incidence of hypertension was the highest in the Xinjiang region.</p></sec></body>
<back>
<ref-list>
<title>References</title>
<ref id="b1-etm-05-05-1439"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kearney</surname><given-names>PM</given-names></name><name><surname>Whelton</surname><given-names>M</given-names></name><name><surname>Reynolds</surname><given-names>K</given-names></name><name><surname>Muntner</surname><given-names>P</given-names></name><name><surname>Whelton</surname><given-names>PK</given-names></name><name><surname>He</surname><given-names>J</given-names></name></person-group><article-title>Global burden of hypertension: analysis of worldwide data</article-title><source>Lancet</source><volume>365</volume><fpage>217</fpage><lpage>223</lpage><year>2005</year></element-citation></ref>
<ref id="b2-etm-05-05-1439"><label>2.</label><element-citation publication-type="book"><article-title>Primary hypertension: Pathogenesis</article-title><source>Kaplan&#x02019;s Clinical Hypertension</source><person-group person-group-type="editor"><name><surname>Kaplan</surname><given-names>NM</given-names></name></person-group><edition>9th edition</edition><publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name><publisher-loc>Philadelphia, PA</publisher-loc><fpage>50</fpage><lpage>121</lpage><year>2006</year></element-citation></ref>
<ref id="b3-etm-05-05-1439"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>W</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Ji</surname><given-names>K</given-names></name><name><surname>Gao</surname><given-names>P</given-names></name><name><surname>Zhu</surname><given-names>D</given-names></name></person-group><article-title>Validation of genetic association in apelin-AGTRL1 system with hypertension in a larger Han Chinese population</article-title><source>J Hypertens</source><volume>28</volume><fpage>1854</fpage><lpage>1861</lpage><year>2010</year></element-citation></ref>
<ref id="b4-etm-05-05-1439"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>W</given-names></name><name><surname>Qi</surname><given-names>Y</given-names></name><name><surname>Hou</surname><given-names>S</given-names></name><name><surname>Zhai</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Qiu</surname><given-names>C</given-names></name></person-group><article-title>Haplotype-based association of the renin-angiotensin-aldosterone system genes polymorphisms with essential hypertension among Han Chinese: the Fangshan study</article-title><source>J Hypertens</source><volume>27</volume><fpage>1384</fpage><lpage>1391</lpage><year>2009</year></element-citation></ref>
<ref id="b5-etm-05-05-1439"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurtz</surname><given-names>TW</given-names></name></person-group><article-title>Genome-wide association studies will unlock the genetic basis of hypertension: con side of the argument</article-title><source>Hypertension</source><volume>56</volume><fpage>1021</fpage><lpage>1025</lpage><year>2010</year></element-citation></ref>
<ref id="b6-etm-05-05-1439"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carlos</surname><given-names>MI</given-names></name></person-group><article-title>Calcium, hypertension and target organ damage: from prevention to regression</article-title><source>Rev Latinoam Hiperte</source><volume>2</volume><fpage>24</fpage><lpage>28</lpage><year>2007</year></element-citation></ref>
<ref id="b7-etm-05-05-1439"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atlas</surname><given-names>SA</given-names></name><name><surname>Volpe</surname><given-names>M</given-names></name><name><surname>Sosa</surname><given-names>RE</given-names></name><name><surname>Laragh</surname><given-names>JH</given-names></name><name><surname>Camargo</surname><given-names>MJ</given-names></name><name><surname>Maack</surname><given-names>T</given-names></name></person-group><article-title>Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system</article-title><source>Fed Proc</source><volume>45</volume><fpage>2115</fpage><lpage>2121</lpage><year>1986</year></element-citation></ref>
<ref id="b8-etm-05-05-1439"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>SZ</given-names></name><name><surname>Zhang</surname><given-names>YM</given-names></name><name><surname>Cheng</surname><given-names>ZH</given-names></name></person-group><article-title>The epidemiological factors in different ethnic hypertension of the Xinjiang Uygur Autonomous Region</article-title><source>China Cardiovascular Magazine</source><volume>12</volume><fpage>179</fpage><lpage>182</lpage><year>1984</year><comment>(In Chinese)</comment></element-citation></ref>
<ref id="b9-etm-05-05-1439"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKie</surname><given-names>PM</given-names></name><name><surname>Ichiki</surname><given-names>T</given-names></name><name><surname>Burnett</surname><given-names>JC</given-names><suffix>Jr</suffix></name></person-group><article-title>M-atrial natriuretic peptide: a novel antihypertensive protein therapy</article-title><source>Curr Hypertens Rep</source><volume>14</volume><fpage>62</fpage><lpage>69</lpage><year>2012</year></element-citation></ref>
<ref id="b10-etm-05-05-1439"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Mao</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Association between human atrial natriuretic peptide Val7Met polymorphism and baseline blood pressure, plasma trough irbesartan concentrations, and the antihypertensive efficacy of irbesartan in rural Chinese patients with essential hypertension</article-title><source>Clin Ther</source><volume>27</volume><fpage>1774</fpage><lpage>1784</lpage><year>2005</year></element-citation></ref>
<ref id="b11-etm-05-05-1439"><label>11.</label><element-citation publication-type="journal"><article-title>Writing Group of 2010 Chinese guidelines for the management of hypertension: 2010 Chinese guidelines for the management of hypertension</article-title><source>Chin J Hypertension</source><volume>19</volume><fpage>701</fpage><lpage>743</lpage><year>2010</year></element-citation></ref>
<ref id="b12-etm-05-05-1439"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>NR</given-names></name><name><surname>Obarzanek</surname><given-names>E</given-names></name><name><surname>Cutler</surname><given-names>JA</given-names></name><etal/></person-group><article-title>Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study</article-title><source>Arch Intern Med</source><volume>169</volume><fpage>32</fpage><lpage>40</lpage><year>2009</year></element-citation></ref>
<ref id="b13-etm-05-05-1439"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Umesawa</surname><given-names>M</given-names></name><name><surname>Iso</surname><given-names>H</given-names></name><name><surname>Date</surname><given-names>C</given-names></name><etal/></person-group><article-title>Relations between dietary sodium and potassium intakes and mortality from cardiovascular disease: the Japan Collaborative Cohort Study for Evaluation of Cancer Risks</article-title><source>Am J Clin Nutr</source><volume>88</volume><fpage>195</fpage><lpage>202</lpage><year>2008</year></element-citation></ref>
<ref id="b14-etm-05-05-1439"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>FJ</given-names></name><name><surname>Marciniak</surname><given-names>M</given-names></name><name><surname>Visagie</surname><given-names>E</given-names></name><etal/></person-group><article-title>Effect of modest salt reduction on blood pressure, urinary albumin, and pulse wave velocity in white, black, and Asian mild hypertensives</article-title><source>Hypertension</source><volume>54</volume><fpage>482</fpage><lpage>488</lpage><year>2009</year></element-citation></ref>
<ref id="b15-etm-05-05-1439"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pol&#x000F3;nia</surname><given-names>J</given-names></name><name><surname>Maldonado</surname><given-names>J</given-names></name><name><surname>Ramos</surname><given-names>R</given-names></name><etal/></person-group><article-title>Estimation of salt intake by urinary sodium excretion in a Portuguese adult population and its relationship to arterial stiffness</article-title><source>Rev Port Cardiol</source><volume>25</volume><fpage>801</fpage><lpage>817</lpage><year>2006</year></element-citation></ref>
<ref id="b16-etm-05-05-1439"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jablonski</surname><given-names>KL</given-names></name><name><surname>Gates</surname><given-names>PE</given-names></name><name><surname>Pierce</surname><given-names>GL</given-names></name><name><surname>Seals</surname><given-names>DR</given-names></name></person-group><article-title>Low dietary sodium intake is associated with enhanced vascular endothelial function in middle-aged and older adults with elevated systolic blood pressure</article-title><source>Ther Adv Cardiovasc Dis</source><volume>3</volume><fpage>347</fpage><lpage>356</lpage><year>2009</year></element-citation></ref>
<ref id="b17-etm-05-05-1439"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><etal/></person-group><article-title>Effects of salt substitute on pulse wave analysis among individuals at high cardiovascular risk in rural China: a randomized controlled trial</article-title><source>Hypertens Res</source><volume>32</volume><fpage>282</fpage><lpage>288</lpage><year>2009</year></element-citation></ref>
<ref id="b18-etm-05-05-1439"><label>18.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Whelton</surname><given-names>PK</given-names></name></person-group><article-title>Potassium and blood pressure</article-title><source>Hypertension Primer</source><person-group person-group-type="editor"><name><surname>Izzo</surname><given-names>JL</given-names></name><name><surname>Black</surname><given-names>HR</given-names></name></person-group><edition>3rd edition</edition><publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name><publisher-loc>Philadelphia, PA</publisher-loc><fpage>280</fpage><lpage>282</lpage><year>2003</year></element-citation></ref>
<ref id="b19-etm-05-05-1439"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>FJ</given-names></name><name><surname>MacGregor</surname><given-names>GA</given-names></name></person-group><article-title>Fortnightly review: Beneficial effects of potassium</article-title><source>BMJ</source><volume>323</volume><fpage>497</fpage><lpage>501</lpage><year>2001</year></element-citation></ref>
<ref id="b20-etm-05-05-1439"><label>20.</label><element-citation publication-type="book"><source>Panel on Dietary Reference Intakes for Electrolytes and Water; Standing Committee on the Scientific Evaluation of Dietary Reference Intakes: Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate</source><publisher-name>National Academies Press</publisher-name><publisher-loc>Washington, DC</publisher-loc><fpage>17</fpage><lpage>223</lpage><year>2005</year></element-citation></ref>
<ref id="b21-etm-05-05-1439"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>BP</given-names></name><name><surname>Wu</surname><given-names>QY</given-names></name><name><surname>Pan</surname><given-names>YJ</given-names></name><etal/></person-group><article-title>Study on measurement of trace element iron content in patients with hypertension and its significance</article-title><source>Chin Clin Med</source><volume>5</volume><fpage>11</fpage><lpage>12</lpage><year>2004</year><comment>(In Chinese)</comment></element-citation></ref></ref-list>
<sec sec-type="display-objects">
<title>Tables</title>
<table-wrap id="t1-etm-05-05-1439" position="float">
<label>Table I</label>
<caption>
<p>Comparison of electrolyte and ANP levels between the EH and NT groups of Kazakh ethnicity.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Factor</th>
<th align="center" valign="middle">NT group (n&#x0003D;266)</th>
<th align="center" valign="middle">EH group (n&#x0003D;229)</th>
<th align="center" valign="middle">t</th>
<th align="center" valign="middle">P-value</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">Age (years)</td>
<td align="center" valign="top">41.44&#x000B1;7.28</td>
<td align="center" valign="top">49.17&#x000B1;8.54</td>
<td align="right" valign="top">&#x02212;8.20</td>
<td align="center" valign="top">0.00</td></tr>
<tr>
<td align="left" valign="top">SBP (mmHg)</td>
<td align="center" valign="top">118.02&#x000B1;11.34</td>
<td align="center" valign="top">141.51&#x000B1;2.94</td>
<td align="right" valign="top">&#x02212;1.56</td>
<td align="center" valign="top">0.00</td></tr>
<tr>
<td align="left" valign="top">DBP (mmHg)</td>
<td align="center" valign="top">75.35&#x000B1;7.32</td>
<td align="center" valign="top">98.22&#x000B1;12.28</td>
<td align="right" valign="top">&#x02212;19.88</td>
<td align="center" valign="top">0.00</td></tr>
<tr>
<td align="left" valign="top">BMI (kg/m<sup>2</sup>)</td>
<td align="center" valign="top">25.04&#x000B1;3.57</td>
<td align="center" valign="top">27.88&#x000B1;5.29</td>
<td align="right" valign="top">&#x02212;5.24</td>
<td align="center" valign="top">0.00</td></tr>
<tr>
<td align="left" valign="top">Serum potassium (mmol/l)</td>
<td align="center" valign="top">4.41&#x000B1;0.42</td>
<td align="center" valign="top">3.92&#x000B1;0.60</td>
<td align="right" valign="top">8.23</td>
<td align="center" valign="top">0.00</td></tr>
<tr>
<td align="left" valign="top">Serum sodium (mmol/l)</td>
<td align="center" valign="top">140.90&#x000B1;3.64</td>
<td align="center" valign="top">141.51&#x000B1;2.94</td>
<td align="right" valign="top">&#x02212;1.56</td>
<td align="center" valign="top">0.12</td></tr>
<tr>
<td align="left" valign="top">ANP (g/l)</td>
<td align="center" valign="top">0.11&#x000B1;0.05</td>
<td align="center" valign="top">0.10&#x000B1;0.06</td>
<td align="right" valign="top">0.30</td>
<td align="center" valign="top">0.77</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn1-etm-05-05-1439">
<p>Results are presented as mean &#x000B1; SD. ANP, atrial natriuretic peptide; EH, essential hypertension; NT, control group; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="t2-etm-05-05-1439" position="float">
<label>Table II</label>
<caption>
<p>Comparison of electrolyte and ANP levels between the EH and NT groups of Uygur ethnicity.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Factor</th>
<th align="center" valign="middle">NT group (n&#x0003D;208)</th>
<th align="center" valign="middle">EH group (n&#x0003D;208)</th>
<th align="center" valign="middle">t</th>
<th align="center" valign="middle">P-value</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">Age (years)</td>
<td align="center" valign="top">43.16&#x000B1;9.37</td>
<td align="center" valign="top">47.62&#x000B1;10.03</td>
<td align="right" valign="top">&#x02212;4.80</td>
<td align="center" valign="top">0.00</td></tr>
<tr>
<td align="left" valign="top">SBP (mmHg)</td>
<td align="center" valign="top">113.48&#x000B1;9.52</td>
<td align="center" valign="top">146.59&#x000B1;9.5</td>
<td align="right" valign="top">&#x02212;22.24</td>
<td align="center" valign="top">0.00</td></tr>
<tr>
<td align="left" valign="top">DBP (mmHg)</td>
<td align="center" valign="top">74.53&#x000B1;7.82</td>
<td align="center" valign="top">99.75&#x000B1;11.19</td>
<td align="right" valign="top">&#x02212;27.12</td>
<td align="center" valign="top">0.00</td></tr>
<tr>
<td align="left" valign="top">BMI (kg/m<sup>2</sup>)</td>
<td align="center" valign="top">25.09&#x000B1;2.97</td>
<td align="center" valign="top">25.97&#x000B1;3.90</td>
<td align="right" valign="top">&#x02212;5.75</td>
<td align="center" valign="top">0.00</td></tr>
<tr>
<td align="left" valign="top">Serum potassium (mmol/l)</td>
<td align="center" valign="top">4.41&#x000B1;0.43</td>
<td align="center" valign="top">4.30&#x000B1;0.48</td>
<td align="right" valign="top">2.43</td>
<td align="center" valign="top">0.02</td></tr>
<tr>
<td align="left" valign="top">Serum sodium (mmol/l)</td>
<td align="center" valign="top">140.98&#x000B1;4.70</td>
<td align="center" valign="top">141.64&#x000B1;4.01</td>
<td align="right" valign="top">&#x02212;1.59</td>
<td align="center" valign="top">0.11</td></tr>
<tr>
<td align="left" valign="top">ANP (g/l)</td>
<td align="center" valign="top">0.26&#x000B1;0.05</td>
<td align="center" valign="top">0.27&#x000B1;0.05</td>
<td align="right" valign="top">&#x02212;2.64</td>
<td align="center" valign="top">0.01</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn2-etm-05-05-1439">
<p>Results are presented as mean &#x000B1; SD. ANP, atrial natriuretic peptide; EH, essential hypertension; NT, control group; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="t3-etm-05-05-1439" position="float">
<label>Table III</label>
<caption>
<p>Comparison of electrolyte and ANP levels between the EH and NT groups of Han ethnicity.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Factor</th>
<th align="center" valign="middle">NT group (n&#x0003D;267)</th>
<th align="center" valign="middle">EH group (n&#x0003D;287)</th>
<th align="center" valign="middle">t</th>
<th align="center" valign="middle">P-value</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">Age (years)</td>
<td align="center" valign="top">42.86&#x000B1;7.52</td>
<td align="center" valign="top">52.81&#x000B1;7.67</td>
<td align="right" valign="top">&#x02212;12.31</td>
<td align="center" valign="top">0.00</td></tr>
<tr>
<td align="left" valign="top">SBP (mmHg)</td>
<td align="center" valign="top">114.73&#x000B1;12.01</td>
<td align="center" valign="top">163.23&#x000B1;22.63</td>
<td align="right" valign="top">&#x02212;24.76</td>
<td align="center" valign="top">0.00</td></tr>
<tr>
<td align="left" valign="top">DBP (mmHg)</td>
<td align="center" valign="top">74.97&#x000B1;7.72</td>
<td align="center" valign="top">97.84&#x000B1;13.23</td>
<td align="right" valign="top">&#x02212;19.56</td>
<td align="center" valign="top">0.00</td></tr>
<tr>
<td align="left" valign="top">BMI (kg/m<sup>2</sup>)</td>
<td align="center" valign="top">24.70&#x000B1;3.20</td>
<td align="center" valign="top">26.49&#x000B1;4.03</td>
<td align="right" valign="top">&#x02212;4.67</td>
<td align="center" valign="top">0.00</td></tr>
<tr>
<td align="left" valign="top">Serum potassium (mmol/l)</td>
<td align="center" valign="top">4.42&#x000B1;0.37</td>
<td align="center" valign="top">4.29&#x000B1;0.48</td>
<td align="right" valign="top">2.64</td>
<td align="center" valign="top">0.01</td></tr>
<tr>
<td align="left" valign="top">Serum sodium (mmol/l)</td>
<td align="center" valign="top">140.58&#x000B1;2.24</td>
<td align="center" valign="top">140.96&#x000B1;3.13</td>
<td align="right" valign="top">&#x02212;1.32</td>
<td align="center" valign="top">0.90</td></tr>
<tr>
<td align="left" valign="top">ANP (g/l)</td>
<td align="center" valign="top">0.13&#x000B1;0.05</td>
<td align="center" valign="top">0.14&#x000B1;0.05</td>
<td align="right" valign="top">&#x02212;2.10</td>
<td align="center" valign="top">0.04</td></tr></tbody></table>
<table-wrap-foot><fn id="tfn3-etm-05-05-1439">
<p>Results are presented as mean &#x000B1; SD. ANP, atrial natriuretic peptide; EH, essential hypertension; NT, control group; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="t4-etm-05-05-1439" position="float">
<label>Table IV</label>
<caption>
<p>Comparison of electrolytes and ANP in the NT groups of different ethnicities.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="middle">Factor</th>
<th align="center" valign="middle">Uygur</th>
<th align="center" valign="middle">Kazakh</th>
<th align="center" valign="middle">Han</th>
<th align="center" valign="middle">F</th>
<th align="center" valign="middle">P-value</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">Age (years)</td>
<td align="center" valign="top">43.16&#x000B1;9.37</td>
<td align="center" valign="top">41.45&#x000B1;7.28</td>
<td align="center" valign="top">42.86&#x000B1;7.52</td>
<td align="right" valign="top">1.85</td>
<td align="left" valign="top">0.158</td></tr>
<tr>
<td align="left" valign="top">SBP (mmHg)</td>
<td align="center" valign="top">113.48&#x000B1;9.52</td>
<td align="center" valign="top">118.02&#x000B1;11.34</td>
<td align="center" valign="top">114.73&#x000B1;12.01</td>
<td align="right" valign="top">7.35</td>
<td align="left" valign="top">0.001<sup><xref rid="tfn5-etm-05-05-1439" ref-type="table-fn">a</xref>,<xref rid="tfn7-etm-05-05-1439" ref-type="table-fn">c</xref></sup></td></tr>
<tr>
<td align="left" valign="top">DBP (mmHg)</td>
<td align="center" valign="top">74.53&#x000B1;7.82</td>
<td align="center" valign="top">75.35&#x000B1;7.32</td>
<td align="center" valign="top">74.97&#x000B1;7.71</td>
<td align="right" valign="top">0.50</td>
<td align="left" valign="top">0.607</td></tr>
<tr>
<td align="left" valign="top">BMI (kg/m<sup>2</sup>)</td>
<td align="center" valign="top">24.09&#x000B1;2.97</td>
<td align="center" valign="top">25.04&#x000B1;3.57</td>
<td align="center" valign="top">24.70&#x000B1;3.20</td>
<td align="right" valign="top">4.13</td>
<td align="left" valign="top">0.02<xref rid="tfn5-etm-05-05-1439" ref-type="table-fn"><sup>a</sup></xref></td></tr>
<tr>
<td align="left" valign="top">Serum potassium (mmol/l)</td>
<td align="center" valign="top">4.41&#x000B1;0.44</td>
<td align="center" valign="top">4.41&#x000B1;0.42</td>
<td align="center" valign="top">4.42&#x000B1;0.37</td>
<td align="right" valign="top">0.03</td>
<td align="left" valign="top">0.97</td></tr>
<tr>
<td align="left" valign="top">Serum sodium (mmol/l)</td>
<td align="center" valign="top">140.98&#x000B1;4.7</td>
<td align="center" valign="top">140.90&#x000B1;3.64</td>
<td align="center" valign="top">140.58&#x000B1;2.24</td>
<td align="right" valign="top">0.61</td>
<td align="left" valign="top">0.54</td></tr>
<tr>
<td align="left" valign="top">ANP (g/l)</td>
<td align="center" valign="top">0.26&#x000B1;0.05</td>
<td align="center" valign="top">0.11&#x000B1;0.05</td>
<td align="center" valign="top">0.13&#x000B1;0.05</td>
<td align="right" valign="top">554.42</td>
<td align="left" valign="top">0.00<sup><xref ref-type="table-fn" rid="tfn5-etm-05-05-1439">a</xref>&#x02013;<xref ref-type="table-fn" rid="tfn7-etm-05-05-1439">c</xref></sup></td></tr></tbody></table>
<table-wrap-foot><fn id="tfn4-etm-05-05-1439">
<p>Results are presented as mean &#x000B1; SD. ANP, atrial natriuretic peptide; EH, essential hypertension; NT, control group; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index.</p></fn><fn id="tfn5-etm-05-05-1439">
<label>a</label>
<p>P&#x0003C;0.05, Uygur vs. Kazakh;</p></fn><fn id="tfn6-etm-05-05-1439">
<label>b</label>
<p>P&#x0003C;0.05, Uygur vs. Han;</p></fn><fn id="tfn7-etm-05-05-1439">
<label>c</label>
<p>P&#x0003C;0.05, Kazakh vs. Han.</p></fn></table-wrap-foot></table-wrap>
<table-wrap id="t5-etm-05-05-1439" position="float">
<label>Table V</label>
<caption>
<p>Comparison of electrolytes and ANP in the EH groups of different ethnicities.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" valign="middle"/>
<th align="center" valign="middle">Uygur</th>
<th align="center" valign="middle">Kazakh</th>
<th align="center" valign="middle">Han</th>
<th align="center" valign="middle">F</th>
<th align="center" valign="middle">P-value</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">Age (years)</td>
<td align="center" valign="top">47.61&#x000B1;10.03</td>
<td align="center" valign="top">49.51&#x000B1;8.54</td>
<td align="center" valign="top">50.47&#x000B1;7.32</td>
<td align="right" valign="top">1.31</td>
<td align="left" valign="top">0.27</td></tr>
<tr>
<td align="left" valign="top">SBP (mmHg)</td>
<td align="center" valign="top">146.59&#x000B1;19.5</td>
<td align="center" valign="top">163.64&#x000B1;25.79</td>
<td align="center" valign="top">163.23&#x000B1;12.62</td>
<td align="right" valign="top">35.78</td>
<td align="left" valign="top">0.00</td></tr>
<tr>
<td align="left" valign="top">DBP (mmHg)</td>
<td align="center" valign="top">99.75&#x000B1;11.19</td>
<td align="center" valign="top">98.22&#x000B1;12.28</td>
<td align="center" valign="top">97.84&#x000B1;12.23</td>
<td align="right" valign="top">1.32</td>
<td align="left" valign="top">0.27</td></tr>
<tr>
<td align="left" valign="top">BMI (kg/m<sup>2</sup>)</td>
<td align="center" valign="top">25.97&#x000B1;3.90</td>
<td align="center" valign="top">27.88&#x000B1;5.29</td>
<td align="center" valign="top">26.49&#x000B1;4.03</td>
<td align="right" valign="top">501.49</td>
<td align="left" valign="top">0.00<sup><xref ref-type="table-fn" rid="tfn9-etm-05-05-1439">a</xref>&#x02013;<xref ref-type="table-fn" rid="tfn11-etm-05-05-1439">c</xref></sup></td></tr>
<tr>
<td align="left" valign="top">Serum potassium (mmol/l)</td>
<td align="center" valign="top">4.30&#x000B1;0.48</td>
<td align="center" valign="top">3.92&#x000B1;0.60</td>
<td align="center" valign="top">4.30&#x000B1;0.48</td>
<td align="right" valign="top">31.18</td>
<td align="left" valign="top">0.00<sup><xref ref-type="table-fn" rid="tfn9-etm-05-05-1439">a</xref>,<xref ref-type="table-fn" rid="tfn11-etm-05-05-1439">c</xref></sup></td></tr>
<tr>
<td align="left" valign="top">Serum sodium (mmol/l)</td>
<td align="center" valign="top">141.64&#x000B1;4.00</td>
<td align="center" valign="top">141.88&#x000B1;3.20</td>
<td align="center" valign="top">141.73&#x000B1;2.53</td>
<td align="right" valign="top">0.23</td>
<td align="left" valign="top">0.8</td></tr>
<tr>
<td align="left" valign="top">ANP (g/l)</td>
<td align="center" valign="top">0.27&#x000B1;0.05</td>
<td align="center" valign="top">0.10&#x000B1;0.06</td>
<td align="center" valign="top">0.14&#x000B1;0.05</td>
<td align="right" valign="top">501.48</td>
<td align="left" valign="top">0.00<sup><xref ref-type="table-fn" rid="tfn9-etm-05-05-1439">a</xref>&#x02013;<xref ref-type="table-fn" rid="tfn11-etm-05-05-1439">c</xref></sup></td></tr></tbody></table>
<table-wrap-foot><fn id="tfn8-etm-05-05-1439">
<p>Results are presented as mean &#x000B1; SD. ANP, atrial natriuretic peptide; EH, essential hypertension; NT, control group; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index.</p></fn><fn id="tfn9-etm-05-05-1439">
<label>a</label>
<p>P&#x0003C;0.05, Uygur vs. Kazakh,</p></fn><fn id="tfn10-etm-05-05-1439">
<label>b</label>
<p>P&#x0003C;0.05, Uygur vs. Han,</p></fn><fn id="tfn11-etm-05-05-1439">
<label>c</label>
<p>P&#x0003C;0.05, Kazak vs. Han.</p></fn></table-wrap-foot></table-wrap></sec></back></article>
